AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About CHRS20270219C0.5
Chemical and pharmaceutical
Coherus Oncology, Inc., was incorporated in Delaware in September 2010. The Company is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative cancer treatments and the commercialization of approved biosimilar combinations. The company's strategy is to build a leading immuno-oncology franchise, funded by cash generated through net sales of a diverse portfolio of U.S. Food and Drug Administration-approved therapies.
